Abstract: A novel method of isolation of TLR4 from cell lysates of mononuclear cells comprising: collecting bovine adult filarial parasites (Setaria digitata); preparing aqueous extracts of setaria digitata (FAg) to produce affinity purified filarial glycoprotein (AgW); isolating human PBMCs from heparinised venous blood samples; subjecting the isolated human PBMCs to the step of incubation to produce PBMC lysates; coupling the said AgW with CNBR activated sepharose; loading the AgW coupled with sepharose and PBMC lysates to an affinity purification column to isolate the receptor recognizing AgW and detecting the reactivity of anti-receptor antibodies and anti-human TLR4 antibodies to the affinity purified receptor using peroxidase conjugated anti-rabbit IgG (in solidphase assay).
Title: A novel method of isolation of TLR4 from cell lysates of mononuclear cells.
FIELD OF INVENTION:
This invention relates to a novel method of isolation of TLR4 from cell lysates of
mononuclear cells.
BACKGROUND OF THE INVENTION:
TLR4 is the first characterized mammalian Toll expessed by a variety of cell types like
macrophages and dendritic cells (Medzhitov, 2001) and responsible for LPS signaling
during Gm-ve bacterial infection (Kawai et al, 2001, Kawai et al, 2011). LPS present in
the cell wall of Gm-ve bacteria binds to LPS binding protein (O Neill et al, 2007). LPS-
LBP complex binds to CD14, a glycosylphosphatidylinositol (GPI) linked protein
expressed on the surface of phagocytes and form a ternary complex (Akira et al, 2006).
The ternary complex then transfers LPS to MD2, a protein associated with TLR4 and
LPS-MD2 complex induce signal via TLR4. LPS-TLR4 signalling resulted in production
of inflammatory mediators like TNF-a, IL-1β, IL-6 and NO ect which play critical role in
protective immunity against bacterial infection. Nitric oxide produced during LPS
signaling is required for control of intracellular infections like Mycobacterium and
Toxoplasma (EI Kasmi et al, 2008). Protection against Gm-ve bacteria was conferred by
TLR4 signalling (Takeuchi et al, 1999). C3H/HeJ mice (TLR4 mutant) are more
susceptible to Gm-ve bacterial infection (Netea et al, 2004, Branger et al, 2004). Later it
was also demonstrated that absence of TLR4 signaling make prone to Salmonella
peritonitis and Klebsiella pneumonia sepsis (Yang et al, 2002, Bernheiden et al, 2001,
Fierer et al, 2002, Knapp et al, 2003). Innate immune activation by TLR antagonists is
helpful in DC maturation and B cell activation; produce critical mediators working as
anti-allergen, anti-cancer and anti-infection, whereas dysregulated innate immunity leads
to development of autoimmunity, sepsis and atherosclerosis (Ishi et al, 2004, Eichacker et
al, 2002, Phillip et al, 2004).
Immunomodulatory components from pathogens (PAMP) are known to induce effective
host immune response through Pattern recognition receptors particularly TLRs but direct
binding of PAMPs to TLRs remain contradictory-LPS signals through TLR4 but does not
directly not bind to TLR4 (da silva et al, 2001). A secreted protein from human hook
worm Necator americans (Hsieh et al, 2004), recombinant Ov-Asp-1 from Onchocerca
volvulus (He et al, 2009) and trehalose dimycolate from M. tuberculosis (Ishikawa et al,
2009) are known to bind directly to antigen presenting cells but the receptors mediating
this interaction are not known. Synthetic bacterial lipopeptide and peptidoglycan binding
to extracellular domain of TLR2 has been demonstrated. (Vasselson et al, 2004, Iwaki et
al, 2002) Another study by Melendez et al reported the direct binding of ES-62, a filarial
glycoprotein to TLR4. We explore this possibility in our study and demonstrate AgW
(affinity purified filarial glycoprotein) binds to TLR4 on the surface of human
monocytes. AgW was coupled to CNBR activated sepharose and an affinity purification
column was prepared through which TLR4 was affinity purified from human
mononuclear cell lysates.
Conventionally recombinant TLR4 proteins are prepared by cloning TLR4 gene. TLR4
gene along with a tag sequence are cloned and expressed in bacteria but there is a
limitation of proper folding of the protein in bacteria but here in this study we report a
novel method by which functionally folded TLR4 can be isolated directly from the host
membrane lysates by an affinity purification column.
OBJECTS OF THE INVENTION:
An object of the present invention is to propose a novel method of isolation of TLR4
from cell lysates of mononuclear cells;
Another object of the present invention is to propose a novel method of isolation of TLR4
by affinity purification column chromatography;
Further, object of the present invention is to propose a novel method by which
functionally folded TLR4 can be isolated directly from the host membrane lysates by an
affinity purification column.
BRIEF DESCRIPTION OF THE INVENTION:
According to this invention there is provided a novel method of isolation of TLR4 from
cell lysates of mononuclear cells comprising:
Collecting bovine adult filarial parasites (Setaria digitata);
preparing aqueous extracts of setaria digitata (FAg) to produce affinity purified filarial
glycoprotein (AgW);
isolating human PBMCs from heparinised venous blood samples;
subjecting the isolated human PBMCs to the step of incubation to produce PBMC
lysates;
coupling the said AgW with CNBR activated sepharose;
loading the AgW coupled with sepharose in an affinity purification column
incubating PBMC lysates in the loaded affinity purification column and isolating the
receptor that binds to AgW.
developing anti-receptor antibodies in rabbits
detecting reactivity of anti-receptor antibodies and anti-human TLR4 antibodies to the
affinity purified receptor using peroxidase conjugated anti-rabbit IgG (in solidphase
assay).
BRIEF DESCRIPTION OF THE ACCOMPANYING DRAWINGS:
Fig-la: Human PBMCs were incubated with biotinylated AgW for 30 minutes at 4°C
followed by staining with Streptavidin-FITC and analysed by FACS. Binding of
biotinylated reagents to monocyte populations are shown.
Fig 1b: Human PBMCs were incubated with biotinylated anti human IgG or anti human
IgM with and without AgW for 30 minutes at 4°C followed by staining with Streptavidin-
FITC and analysed by FACS. Binding of biotinylated reagents to monocyte populations
are shown.
Fig 1c: ELISA plates were coated with human IgG (purified from protein A sepharose
coloumn). After blocking with skimmed milk PBS, anti-receptor antibodies were
incubated. Binding of anti receptor antibody was detected by using peroxidase conjugated
anti-rabbit IgG. Anti-human IgG HRP was taken as a positive control. The enzyme
activity was measured using OPD.
Fig-2a: ELISA plates were coated with valine, serpin, alt-1, alt-2, ES antigens, L3
antigens, FAg and AgW incubated with biotinylated affinity purified receptors and
probed with avidin peroxidase. The enzyme activity was measured using OPD.
Fig-2b: ELISA plates were coated with different concentrations of AgW incubated with
biotinylated affinity purified receptors and probed with avidin peroxidase. The enzyme
activity was measured using OPD.
Fig-3 shows that different concentrations of affinity purified receptors were coated in an
ELISA plate and incubated with anti-rabbit TLR4 antibodies and probed with anti-rabbit
IgG peroxidase. The enzyme activity was measured using OPD.
Fig 4a: shows that Human PBMCs were incubated with rabbit anti-receptor antibodies
with and without AgW and probed with anti-rabbit IgG FITC and analysed by FACS.
Binding of both the antibodies to monocytes population is shown.
Fig 4b: shows that Human PBMCs were incubated with rabbit anti-TLR4-PE antibodies
with and without AgW and analysed by FACS. Binding of both the antibodies to
monocytes population is shown.
Fig. 4c: Human PBMCs were incubated with rabbit anti-receptor antibodies and anti-
TLR4 PE antibodies. The cells were then probed with anti-rabbit IgG FITC and analysed
by FACS. Representative dots in the right upper quadrant showing the cells binding to
both the antibodies.
Fig. 4d: Human PBMCs were incubated with anti-TLR4 PE antibodies with and without
anti-receptor antibodies analysed by FACS.
Fig. 4e: Murine bone marrow macrophages were incubated with anti-receptor antibodies
and probed with anti-rabbit IgG FITC and analysed by FACS.
Fig-5a: Soluble TLR4 is recognized by anti-receptor antibodies in solidphase.
Extracts of S.digitata, AgW, N.bracilliences, H.polygyrus were coated in an ELISA plate.
After blocking with 1% skimmed milk-PBS, lysates of human PBMCs were incubated
for 2 hr at 37 C. The plates were thoroughly washed and were incubated with anti-mouse
TLR4 and anti-receptor antibodies and bound antibody was detected using peroxidase
conjugated anti-rabbit IgG. The enzyme activity was measured using OPD. % mean
+SEM of two individual experiments are shown.
Fig 5b: Affinity purified receptor was separated in a non reducing gel and then
transferred to a nitrocellulose membrane. The membrane was blocked using 5%
Skimmed milk PBS and probed with anti-receptor antibodies followed by anti-rabbit IgG
peroxidase. Enzyme activity was detected using DAB.
Fig 6a,b: mouse (BALB/C) BMDMs were cultured in sterile Dulbecco's modified eagles
medium containing 10% heat inactivated fetal calf serum in humidified atmospheric
condition(5% CO2,80% humidity). After 8-10 hrs incubation at 37°C non adherent cells
were removed by washing with sterile medium. The remaining adherent cells were
stimulated with LPS with and without anti-receptor antibodies for 48 hrs. Culture
supernatants were harvested and TNF-α, IL-1β was quantified according to the
manufacturer's instruction and nitrite by Griess reagent.
Fig 6c: BALB/C mice were injected IP with lethal dose of LPS (15mg/Kg body wt) with
or without anti-receptor antibodies (100µg) and the mortality was scored. (n=10).
DETAILED DESCRIPTION OF THE INVENTION:
Collection of bovine adult filarial parasites (Setaria digitata)
Peritoneal dwelling adult female filarial parasites (Setaria digitata) were collected from
cattle in a local abattoir, attached to the local zoological park at Nandankanan,
Bhubaneswar after obtaining necessary approval from zoo authorities. The worms were
transported to the laboratory in Dolbecco's Modified Eagles Medium (DMEM) (Sigma)
pH 7.00 containing antibiotics [Penicillin Streptomycin solution 1 ml/100 ml of medium]
(Sigma) and 1 % glucose (Hi-media).
Preparation of AgW and labeling: -
Aqueous extracts of S. digitata (designated as FAg) was prepared by homogenization
followed by ultrasonication. One milligram of FAg was passed through WGA-Sepharose
(Sigma) column and the unbound proteins were washed by passing PBS and
glycoproteins bound to WGA were eluted by Glycine-HC1 buffer (pH 3.6).The pH of the
elutes was adjusted using 0.1 M NaOH and dialysed against PBS. Protein concentration
of the elute (AgW) was estimated and stored at -20° C for further use.AgW was
biotinylated using appropriate derivatives of biotin i.e. N-hydroxysuccinamide
derivatives (Sigma) suitable for protein labeling.
Lyophilized Brugia pahangi somatic extracts were kindly gifted by Dr. E. Devaney,
University of Glasgow, UK and aqueous extracts of Nippostrongylus brasiliensis and
Heligomosomoides polygyria were gifted by Dr.Rick maizel, University of Edinburgh,
UK.
Animals
BALB/C mice were obtained from National Institute of Immunology, New Delhi which
was originally imported from Jackson laboratories, Germany. Breeding and maintenance
were done at the animal facility at Institute of Life Sciences, Bhubaneswar, India. 8-10
weeks old animals were used for this study. Institutional animal ethics committee of
Institute of Life Sciences, Bhubaneswar approval was obtained for all the investigations
conducted in mice.
Bone marrow cells culture.
Mouse bone marrow cells were collected from femoral shafts by flushing with 3 ml. of
cold sterile DMEM (Sigma) supplemented with 20mM of L-Glutamine (ICN),
antibiotics (1ml penicillin and streptomycin /100 ml of medium) (Sigma)containing 10%
FBS. The cell suspension was passed through a sieve to remove large clumps. The cell
suspension was washed 2-3 times with sterile DMEM and adjusted to 0.5X 106cells/well
and cultured in 24 well plates. After 8-10 hrs incubation at 37°C non adherent cells were
removed by washing with sterile DMEM and the adherent cells were stimulated with LPS
(Sigma) with or without anti receptor antibodies at 10µg/ml and 100 µg concentration
respectively. After 48 hrs the supernatants were aspirated, frozen at -80° c and used later
for estimation of cytokine levels.
HUMAN BLOOD SAMPLES
The study population was drawn from areas in and around Bhubaneswar, Orissa. About
5ml. of nocturnal blood each was collected in heparinised glass vials from the selected
human study population as per the ethical guidelines of ILS, Bhubaneswar, Orissa.
Isolation of Human PBMCs and culture
Human PBMCs were isolated from heparinised venous blood samples by density gradient
centrifugation method using Histopaque (Sigma). Briefly, the heparinised blood was
layered on LSM medium gently in the ratio of 1:1 and subjected to centrifugation at1000
RPM for 30 minutes. The white layer representing PBMCs was aspirated out gently and
transferred aseptically into sterile centrifuge tubes. The suspension of cells was then
washed and used in binding study.
Preparation of PBMC lysates
Human PBMCs (2 X 106) were incubated with 2 ml of cell lysis solution (Sigma) and a
cocktail of protease inhibitors (Sigma) for one hr. at 4° C and then ultra-sonicated. The
supernatant was collected by centrifuging at 4000 RPM for 10 minutes and stored for
further use.
Isolation of receptor recognizing AgW
AgW was coupled to CNBR activated sepharose and loaded in an affinity purification
column and washed thoroughly to remove the uncoupled AgW. Human PBMC lysates
were incubated in the column at 37° c for 30 minutes and then the column was washed by
PBS to remove the unbound proteins. The proteins bound to AgW column were eluted
using Glycine HC1 buffer (pH 3.6). The pH of the elutes was adjusted using 0.1 M NaOH
and dialysed against PBS. The eluted protein concentration was measured and stored at -
20° C for further use.
Preparation of polyclonal anti-receptor antibodies in rabbits
A rabbit was immunized with 0.3 mg of affinity purified receptor with Complete Freunds
Adjuvant subcutaneously. Three booster dosages were given. One is with incomplete
freunds adjuvant intramuscularly and the second and third is without adjuvant, intra
peritoneally. Pre bleed was collected from the animal prior to immunization. Serum was
collected on day 55 and the titer of polyclonal antibody was checked in solid phase assay.
Quantification of Cytokines
Supernatants from mouse BMDM cultures were analysed for levels of TNF-α, IL-1β by a
sandwich ELISA according to manufacturer's instruction using commercially available
ELISA kits (e-Biosciences).
Nitrite estimation
Nitrite concentration was estimated using Griess reagent. Culture supernatant or
plasma was mixed with equal volume of Griess reagent (1% of sulfalinamide and 0.1% of
N-(l-napthyi ethylenediamine in 2.5% H3P04). After 15 minutes incubation at room
temperature the nitrite concentration was measured at 540 nm using a microplate reader.
Sodium nitrite (12.5-200µm) was used as nitrite standards.
Flow Cytometry
Human PBMCs or mouse BMDM (1X 106/ml) were stained for 30 minutes at 4°C with
fluorescence labeled antibodies specific to CD 14, TLR4 (e Biosciences) or affinity
purified receptors mixed with and without AgW along with relevant isotype controls.The
cells were thoroughly washed to remove the unbound antibodies and analysed by FACS
(BD FACS caliber).
Enzyme Linked Immunosorbent Assay.
ELISA plates (Nunc maxisorp) were coated with lug of PBS extracts of S.digitata,
AgW, N.brasiliensis, H.polygyrus. After blocking with 1% skimmed milk-PBS (Hi-
media), human PBMC lysates were incubated for 2 hr at 37°C. The plate was thoroughly
washed and were incubated with rabbit anti-receptor antibodies and rabbit anti-human
TLR4 (e Biosciences) antibodies. The binding of anti-receptor antibodies and anti-human
TLR4 was detected by using peroxidase conjugated anti-rabbit IgG (Sigma). The enzyme
activity was measured using OPD (Sigma).
SDS page and Weastern bloting-
Lysates of human PBMCs were separated on 10% polyacrylamide gels and transferred to
nitrocellulose membranes (Millipore).The nitrocellulose membrane was blocked for
overnight with 5% skimmed milk-PBS. The membrane was washed thoroughly for 5-6
times with PBS-tween and incubated with anti-receptor antibodies followed by anti-rabbit
IgG peroxidase antibodies. The enzyme activity was detected using DAB.
Mouse Model of Endotoxemia
8-10 weeks old BALB/C mice were intraperitoneally injected with 15mg/Kg body wt
LPS with control and anti receptor antibodies and observed for mortality a period over
168 hrs.
AgW binds to TLR4 on the surface of human monocytes.
We tested the binding property of an affinity purified filarial glycoprotein (AgW) while
searching for an elusive innate receptor for helminthes or helminth products. Biotinylated
AgW directly bound to the surface of human monocytes (Fig-1a). We exclude the
possibility of binding of AgW to cytophillic antibodies on the cell surface by a
competitive inhibition assay. AgW failed to inhibit the reactivity of anti-human IgG or
anti- human IgM antibodies to the monocytes suggesting that AgW is not recognized by
cytophillic antibodies on the surface of monocytes rather it is recognized by a receptor on
the monocytes surface (Fig-1 b). A filarial antigen ES-62 is known to bind dendritic cells
through TLR4, so we tested this possibility. Reactivity of anti TLR4 antibodies was
inhibited by this binding suggesting that AgW bound to TLR4 on the surface of
monocytes (Fig 1c).
Affinity purified receptor binds to AgW on solid phase.
Using the binding property of AgW to monocytes we affinity purified the receptor and
validated in solid phase assay. Biotinylated affinity purified receptor was demonstrated to
bind to AgW on solidphase assay. ELISA plates were coated with both filarial and non
filarial proteins and incubated with biotinylated receptor followed by streptavidin-
peroxidase. It was observed that the affinity purified receptor binds to AgW containing
filarial proteins whereas it fails to bind to control proteins like BSA, Myosin or larninin
(Fig-2a). Affinity purified receptor also bind AgW in a dose dependent manner revealing
its specificity (Fig-2b).
Affinity Purified receptor is TLR4.
As it was demonstrated that AgW binds to TLR4 we tested this possibility. An ELISA
plate was coated with affinity purified receptor followed by incubation with anti-TLR
antibodies. Anti-TLR4 antibodies reacted with affinity purified receptor in a dose
dependent manner suggesting that the affinity purified receptor is TLR4 (Fig-3).
Reactivity of anti-receptor antibody as well as anti-TLR4 antibodies to the cell
surface is inhibited by AgW.
As part of the characterization process of the affinity purified receptor we raised a
polyclonal antibody against the affinity purified receptor (anti-receptor antibodies) in
rabbit and compare it with commercially available anti-TLR4 antibodies. Reactivity of
both the antibodies to the surface of human monocytes was comparable. Further the
reactivity of both the antibodies to human monocytes was inhibited by AgW (Fig-4a,b).
Both the antibodies bind to surface of the same population of monocytes (Fig-4c) and
reactivity of anti-TLR4 antibodies was inhibited by anti-receptor antibodies (Fig-4d).
Anti-receptor antibodies were also bind to murine bone marrow macrophages (Fig-4e).
Soluble TLR4 is recognized by anti-receptor antibodies.
The affinity of the anti-receptor antibody to TLR4 was validated in a solidphase assay.
Different helminthic antigens were coated in an ELISA plate followed by incubation with
membrane lysates of human PBMCs (containing TLR4) and then with both anti-TLR4
and anti-receptor antibodies. It was demonstrated that reactivity of both the antibodies are
comparable (Fig-5a). Further binding of anti-receptor antibodies to TLR4 was confirmed
by western blotting. Soluble membrane lysates of human PBMCs were separated in a
native SDS PAGE and then transferred to a nitrocellulose membrane. The nitrocellulose
membrane was probed with anti-receptor antibodies and it was observed that anti-
receptor antibodies bind to a protein of 90 KD mol wt. equivalents to the mol.wt. of
TLR4 (Fig-5b).
LPS induced signaling and endotoxic shock was inhibited by anti-receptor
antibodies.
The role of anti-TLR4 or anti-TLR4/MD2 antibodies in blocking LPS induced signaling
is well documented (Bruno et al, 2008, Thierry et al, 2009). We validated the efficiency
of anti-receptor antibodies in blocking of LPS signaling. Murine bone marrow derived
macrophages were stimulated with LPS with and without anti-receptor antibodies for
48hrs. Levels of TNF-α, IL-1β and nitrite were quantified in the culture supernatants. It
was observed that LPS induced mediators were inhibited by anti-receptor antibodies (Fig-
6a,b). We sought a direct in vivo validation of anti-receptor antibodies by administering it
to a mouse model of endotoxemia. Co-administration of lethal dose of LPS and anti-
receptor antibodies protected mice from endotoxic shock (Fig-6b).
A simple and efficient method to isolate TLR4 from the cell lysates of human peripheral
mononuclear cells. This procedure doesn't require complex equipments and skills and
easier than tedious conventional methods that require recombinant DNA technology.
Conventionally Fusion protein is prepared by cloning the TLR4 gene along with a tag
sequence and allowed to express in bacteria. As the splicing and protein folding
mechanism in bacteria is not so well equipped as eukaryotes, the functional folding of the
protein along with the tag is doubtful. In this study we discovered a very rapid,
convenient and easy method by means of which functionally folded TLR4 can be purified
through an affinity purification column. The affinity purification column was prepared by
coupling AgW with cyanogen bromide activated sepharose which is easier and required
less skill than cloning and expressing a fusion protein. Further it is very less expensive
than the costly molecular biological tools like plasmids or restriction enzymes. The
column can be reused at least three times if proper storage care is taken.
This method of isolation will provide an ideal tool and will open new possibilities for the
researchers who are unable to pursue their research on TLR4 due to lack of commercial
reagents. As an instance our group (unpublished observations) established that gerbils are
far more susceptible to endotoxic shock than Mastomys. 1/40 th of the lethal dose of
Mastomys is enough to cause endotoxic shock and death in gerbils. The first question
need to be answered in the above paradoxical models is whether differential expression
of TLR4 takes place in both the species but it cannot be pursued due to lack of anti-
gerbil/anti-Mastomys TLR4 antibodies. Gram negative bacterial infection, endotoxemia
and sepsis is a common phenomenon in horse (Morris, 1991). Again the expression and
function of TLR4 cannot be examined due to unavailability of commercial reagents. Even
plant biologists interested to pursue their research on plant TLRs as Gram negative
bacterial infection causes a great loss to agriculture, are facing the same problem. To
pursue TLR4 research in all the organisms apart from fruit fly to humans, TLR4
antibodies can't be prepared by the conventional method because genome sequence for
all the organisms is yet to be deciphered. As susceptibility to Gram negative bacterial
infection and endotoxemia varies from species to species, study of species specific three
dimensional crystallographic structure, sequence and protein folding of TLR4 is required
to understand the mechanism for which functionally folded TLR4 from the organism
need to be isolated. Species specific variation and expression can't be studied by isolating
a fusion protein. By this simple method described here TLR4 from any species can be
isolated easily and anti-TLR4 antibody can be prepared. Not only TLR4 but also other
TLRs and scavenger receptors having a known directly binding ligand can also be
isolated by this method.
Efficiency of anti-TLR4 antibodies is well documented in blocking Gram negative
bacterial infection and sepsis. Anti-TLR4 antibodies (Roger et al, 2009, Spiller et al,
2008) and anti-TLR4/MD2 antibodies (Daubeuf et al, 2007) were demonstrated to block
LPS induced signaling and protected from Gram negative bacterial infection and death.
Another study reported anti-TLR4/MD2 antibodies offers protection against TNF-α
induced hepatitis (Akashi et al, 2006). TLR2 driven septic shock by PAM3CSK or
B.subtilis infection could be blocked by anti-TLR2 antibodies (Meng et al, 2004).
Furthermore it was demonstrated that administration of soluble TLR4 also blocks LPS
signaling (Roger et al, 2009). In this study we developed polyclonal antibodies against
the affinity purified receptor which protected mice from lethal endotoxic shock. Gram
negative bacterial infection is a very common and an alarming problem in all the
organisms from lower plants to human beings and TLR4 remain conserved in all the
organisms, application of soluble TLR4 or anti-TLR4 antibodies may be a useful which
can be prepared by this simple method. Considering all the above applications we
concede the method of TLR4 isolation by affinity purification may be a useful tool in
TLR research by which TLR from any species can be isolated in native form.
WE CLAIM:
1. A novel method of isolation of TLR4 from cell lysates of mononuclear cells
comprising:
collecting bovine adult filarial parasites (Setaria digitata);
preparing aqueous extracts of setaria digitata (FAg) to produce affinity purified filarial
glycoprotein (AgW);
isolating human PBMCs from heparinised venous blood samples;
subjecting the isolated human PBMCs to the step of incubation to produce PBMC
lysates;
coupling the said AgW with CNBR activated sepharose;
loading the AgW coupled with sepharose to an affinity purification column;
incubating PBMC lysates with in the loaded affinity purification column to isolate the
AgW recognizing receptor.
incubating the affinity purified receptor with rabbit anti-receptor antibodies and rabbit
antihuman TLR4 antibodies detecting the binding of the affinity purified receptors to the
said antibodies.
2. The method as claimed in claim 1, wherein FAg is prepared by homogenization
followed by ultrasonication.
3. The method as claimed in claim 1, wherein AgW was biotinylated using appropriate
derivatives of biotin i.e. N-hydroxysuccinamide derivatives suitable for protein labeling.
4. The method as claimed in claim 1 wherein the step of isolation of PBMC is done by
density gradient centrifugation method using Histopaque.
5. The method as claimed in claim 1, wherein the PBMC were incubated with 2 ml of cell
lysis solution and a cocktail of protease inhibitors for 1 hour at 4°C and then
ultrasonicated.
6. The method as claimed in claim 1, wherein the human PBMC lysates were incubated
in the column at 37°c for 30 minutes and then the column was washed by PBS to remove
the unbound proteins and the proteins bound to AgW column were eluted using glycine
HC1 buffer.
7. The method as claimed in claim 1, wherein the said polyclonal anti-receptor antibodies
in rabbits were prepared by immunizing a rabbit with 0.3 mg of affinity purified receptor
with complete Freunds Adjuvant subcutaneously.
A novel method of isolation of TLR4 from cell lysates of mononuclear cells comprising:
collecting bovine adult filarial parasites (Setaria digitata); preparing aqueous extracts of
setaria digitata (FAg) to produce affinity purified filarial glycoprotein (AgW); isolating
human PBMCs from heparinised venous blood samples; subjecting the isolated human
PBMCs to the step of incubation to produce PBMC lysates; coupling the said AgW with
CNBR activated sepharose; loading the AgW coupled with sepharose and PBMC lysates
to an affinity purification column to isolate the receptor recognizing AgW and detecting
the reactivity of anti-receptor antibodies and anti-human TLR4 antibodies to the affinity
purified receptor using peroxidase conjugated anti-rabbit IgG (in solidphase assay).
| # | Name | Date |
|---|---|---|
| 1 | 1213-KOL-2011-(07-10-2011)-PA.pdf | 2011-10-07 |
| 1 | 1213-KOL-2011-AbandonedLetter.pdf | 2017-10-07 |
| 2 | 1213-KOL-2011-(07-10-2011)-FORM 1.pdf | 2011-10-07 |
| 2 | 1213-KOL-2011-FER.pdf | 2017-03-10 |
| 3 | 1213-KOL-2011-Other Patent Document-250215.pdf | 2015-03-26 |
| 3 | 1213-KOL-2011-(07-10-2011)-CORRESPONDENCE.pdf | 2011-10-07 |
| 4 | 1213-KOL-2011-FORM 18.pdf | 2011-10-31 |
| 4 | 1213-KOL-2011-ABSTRACT.pdf | 2011-11-03 |
| 5 | ABSTRACT-1213-KOL-2011.jpg | 2011-11-03 |
| 5 | 1213-KOL-2011-CLAIMS.pdf | 2011-11-03 |
| 6 | 1213-KOL-2011-SPECIFICATION.pdf | 2011-11-03 |
| 6 | 1213-KOL-2011-CORRESPONDENCE.pdf | 2011-11-03 |
| 7 | 1213-KOL-2011-FORM-3.pdf | 2011-11-03 |
| 7 | 1213-KOL-2011-DESCRIPTION (COMPLETE).pdf | 2011-11-03 |
| 8 | 1213-KOL-2011-DRAWINGS.pdf | 2011-11-03 |
| 8 | 1213-KOL-2011-FORM-2.pdf | 2011-11-03 |
| 9 | 1213-KOL-2011-FORM-1.pdf | 2011-11-03 |
| 10 | 1213-KOL-2011-FORM-2.pdf | 2011-11-03 |
| 10 | 1213-KOL-2011-DRAWINGS.pdf | 2011-11-03 |
| 11 | 1213-KOL-2011-FORM-3.pdf | 2011-11-03 |
| 11 | 1213-KOL-2011-DESCRIPTION (COMPLETE).pdf | 2011-11-03 |
| 12 | 1213-KOL-2011-SPECIFICATION.pdf | 2011-11-03 |
| 12 | 1213-KOL-2011-CORRESPONDENCE.pdf | 2011-11-03 |
| 13 | ABSTRACT-1213-KOL-2011.jpg | 2011-11-03 |
| 13 | 1213-KOL-2011-CLAIMS.pdf | 2011-11-03 |
| 14 | 1213-KOL-2011-FORM 18.pdf | 2011-10-31 |
| 14 | 1213-KOL-2011-ABSTRACT.pdf | 2011-11-03 |
| 15 | 1213-KOL-2011-Other Patent Document-250215.pdf | 2015-03-26 |
| 15 | 1213-KOL-2011-(07-10-2011)-CORRESPONDENCE.pdf | 2011-10-07 |
| 16 | 1213-KOL-2011-FER.pdf | 2017-03-10 |
| 16 | 1213-KOL-2011-(07-10-2011)-FORM 1.pdf | 2011-10-07 |
| 17 | 1213-KOL-2011-AbandonedLetter.pdf | 2017-10-07 |
| 17 | 1213-KOL-2011-(07-10-2011)-PA.pdf | 2011-10-07 |
| 1 | searchstrategy_03-03-2017.pdf |